VanEck Global Healthcare Leaders ETF (HLTH) Review & Analysis
- β0.4% in September (total return), behind the median international shares ETF at +0.0%.
- Investors added a net $2.4m (4.2% of the fund).
- The unit price closed the month at $11.88, 9% below its 12-month high (range $10.50 to $13.00).
About HLTH
HLTH is an international shares ETF from VanEck, listed on the ASX since September 2020. With $59m under management it is number 167 of 254 international shares ETFs by size. The management fee is 0.45% a year, about $45 on every $10,000 invested, cheaper than the typical international shares ETF at 0.55%.
Its largest holdings are UCB SA, Mettler-Toledo International Inc and Eli Lilly & Co, and the top 10 make up 23% of the fund. By sector it leans towards health care (98%) and financials (2%). United States is the biggest country exposure at 66%.
Over five years it has returned β0.1% a year including distributions, against +8.8% for the median international shares ETF. With its focus on healthcare, it is the kind of fund many investors use as a smaller satellite holding alongside a diversified core.
HLTH distributions and dividend dates
HLTH pays distributions yearly, usually going ex-distribution in July, with payment about 26 days after the ex-date. (Pattern estimated from recent payments.)
The latest distribution was $0.04 per unit (0% franked), ex-distribution on 1 July 2026 and paid on 27 July 2026. To receive it you need to own HLTH before the ex-date.
Its distribution yield over the past 12 months is about 0.3%. Distributions vary and past payments are not a guide to future ones.
From ASX announcements, updated nightly. See every ETF in the dividend calendar.
Compare HLTH with
| Fee | 0.45% | 0.59% |
| 1 year | +5.5% | +6.2% |
| 5 yrs p.a. | β0.1% | +8.5% |
| Size | $59m | $3.8bn |
| Fee | 0.45% | 0.41% |
| 1 year | +5.5% | +14.9% |
| 5 yrs p.a. | β0.1% | +5.9% |
| Size | $59m | $1.5bn |
| Fee | 0.45% | 0.13% |
| 1 year | +5.5% | +17.1% |
| 5 yrs p.a. | β0.1% | +11.0% |
| Size | $59m | $1.1bn |
| Fee | 0.45% | 0.35% |
| 1 year | +5.5% | +8.9% |
| 5 yrs p.a. | β0.1% | +9.2% |
| Size | $59m | $1.1bn |
HLTH price by TradingView
| Stock Code | HLTH |
|---|---|
| Fund Manager | VanEck |
| Asset Class | International shares |
| AUM | $59m |
| MER (%) | 0.45% |
| Net flows (Sep) | +$2.4m |
| Last Price | $11.88 |
| 52-Week Range | $10.50 β $13.00 |
| Bid/Ask Spread | 0.21% |
| Listing Date | 10/09/2020 |
| Exchange | ASX |
| Index tracked | MarketGrader Developed Markets ex Australia Health Care AUD Index |
| Issuer website | VanEck β |
Performance (% return)
$10,000 investedβ¦
Value at 30 September 2026 with distributions reinvested, before tax and brokerage.
Total returns including distributions, to 30 September 2026. 1M, 1Y, 3Y and 5Y bars are cumulative.